A genetic mutation that causes chronic myeloid leukemia (CML), the Philadelphia chromosome was first detected in 1959. Some fifty years later, the once deadly CML can be controlled with a daily dose of a drug called Gleevec. Wapner, a widely published science writer, Work in Progress blogger, and former editor of Oncology Spectrum, profiles the dedicated doctors involved in the research and explains the science behind this breakthrough.